Ads
related to: vitreomacular traction and macular hole
Search results
Results from the WOW.Com Content Network
Vitreomacular traction syndrome (VTS) is a medical condition in the eye that is the result of tractional forces (pulling) being placed on the retina. [ 1 ] [ 2 ] VTS is common in people who have an incomplete posterior vitreous detachment, a type of retinal detachment at the periphery of the retina. [ 1 ]
Traction caused by VMA is the underlying pathology of an eye disease called symptomatic VMA. There is evidence that symptomatic VMA can contribute to the development of several well-known eye disorders, such as macular hole and macular pucker, that can cause visual impairment, including blindness.
Macular hole on the right eye Classification of Vitreomacular Adhesion, Traction, and Macular Hole (IVTS 2013). Macular degeneration is a condition affecting the tissues lying under the retina, while a macular hole involves damage from within the eye, at the junction between the vitreous and the retina itself.
"The International Vitreomacular Traction Study Group classification of vitreomacular adhesion, traction, and macular hole [43]" Authors: Jay S Duker, Peter K Kaiser, Susanne Binder, Marc D de Smet, Alain Gaudric, Elias Reichel, SriniVas R Sadda, Jerry Sebag, Richard F Spaide, Peter Stalmans, Ophthalmology 120 (12), 2611-2619, 2013.
This may be present in conditions causing traction on the retina especially at the macula. [5] This may occur in: a) The vitreomacular traction syndrome; b) Proliferative diabetic retinopathy with vitreoretinal traction; c) Atypical cases of impending macular hole.
Ocriplasmin, sold under the brand name Jetrea, is a recombinant protease with activity against fibronectin and laminin, components of the vitreoretinal interface.It is used for treatment of symptomatic vitreomacular adhesion, for which it received FDA approval on 17 October 2012.
Ads
related to: vitreomacular traction and macular hole